Articles in Press
Volume 4 Issue 1
The Multi-Target Therapy Approach to Stop Multiple Sclerosis Progression
de Font-Réaulx Enrique MD, MSc*
Multiple Sclerosis (MS) is one of the neurodegenerative diseases that have caught the most attention in the last 4 decades. Although there are several treatments to stop progression, none of them has been designed specifically for this disease until now. Each of these treatments has only one action mechanism and is an immunomodulator or immunosupressor with varying results with frequent collateral effects. Here is described the first oral Multi-Target Treatment (MTT) specifically designed to halt disease progression.